Global Nuclear Medicine Market Size, Trends and Forecast by 2022

According to Stratistics MRC, the Global Nuclear Medicine Market is valued at $4.42 billion in 2015 and is expected to grow at a CAGR of 10.55 % to reach $8.92 billion by 2022. Rising demand from emerging nations and the growing incidence of cardiovascular ailments and cancers are some of the key factors driving the market growth. Conversely, strict government regulations and competition from conventional diagnostic methods are hampering the market. Furthermore, technological advancements in neurological applications are anticipated to create ample of opportunities for the market in the future.

Browse the report: http://www.orbisresearch.com/reports/index/nuclear-medicine-global-market-outlook-2015-2022

North America is the largest market in terms of revenue in 2015 due to several technological advancements within the region. However, Asia Pacific is poised to grow at a faster pace due to the increasing incidence of neurological and cardiovascular diseases and cancer. Various new products are being launched together with the several technological advancements. Thus, new product launch is the key strategy followed by the players to gain the traction in the market.

Some of the key players in global Nuclear Medicine market are Advanced Accelerator Applications S.A., Ashby Gorman Baker Ltd, Bayer Healthcare, Bracco Imaging S.P.A, Cardinal Health, Digirad, Eczcibasi-Monrol Nuclear Products, GE Healthcare, IBA Molecular Imaging, Lantheus Medical Imaging, Mallinckrodt PLC, Mediso Ltd., Nordion, Inc., Philips Healthcare and Siemens Healthcare.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184755

Applications Covered:
Therapeutics
Bone Metastasis
Endocrine Tumors
Lymphoma
Thyroid
Nephrology
Cardiology
Neurology
Other Therapeutic Applications
Diagnostics
Positron emission tomography (PET)
Single Photon Emission Computed Tomography (SPECT)

Types of Nuclear Medicine Covered:
Nuclear Medicine Therapeutic Isotopes
Alpha Emitters
Brachytherapy
Beta Emitters
Nuclear Medicine/Radiopharmaceuticals Diagnostics
Positron emission tomography (PET) Radiopharmaceuticals
Single photon emission tomography (SPECT)
Procedure Volumes Covered
Therapeutic
Alpha Emitters
Beta Emitters
Brachytherapy
Diagnostics
Single photon emission tomography (SPECT) Radiopharmaceuticals
Positron emission tomography (PET) Radiopharmaceuticals

End Users Covered:
Therapeutic
Alpha Emitters
Beta Emitters
Brachytherapy
Diagnostics
Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Positron Emission Tomography (PET) Radiopharmaceuticals
Stable Isotopes Covered:
Sulphur (S-32)
Oxygen (O-18)
Nitrogen (N-15)
Deuterium (D2)
Carbon (C-13)
Other Stable Isotopes

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com